A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly
Clinical trial NCT04522180 · COMPLETED
Trial details
- NCT number
- NCT04522180
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2022-07-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.